Showing 1 - 9 results of 9 for search 'Min-ke He', query time: 0.04s Refine Results
  1. 1
    Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma

    Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma by Yang Zhao, JiaYing Lai, RunBin Liang, MinKe He, Ming Shi

    Published 2019-05-01
    Get full text
    Article
  2. 2
    NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma

    NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma by Yong Le, Anna Kan, Qi-Jiong Li, Min-Ke He, Hai-Long Chen, Ming Shi

    Published 2019-09-01
    Get full text
    Article
  3. 3
    Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro

    Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro by Yu-Jie Xu, Min-Ke He, Shuang Liu, Li-Chang Huang, Xiao-Yun Bu, Anna Kan, Ming Shi

    Published 2021-11-01
    Get full text
    Article
  4. 4
    Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study

    Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study by Min-Ke He, Yong Le, Qi-Jiong Li, Zi-Shan Yu, Shao-Hua Li, Wei Wei, Rong-Ping Guo, Ming Shi

    Published 2017-10-01
    Get full text
    Article
  5. 5
    Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy

    Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy by Hai‐Long Chen, Han‐Yue OuYang, Yong Le, Peng Jiang, Hui Tang, Zi‐Shan Yu, Min‐Ke He, Yun‐Qiang Tang, Ming Shi

    Published 2018-11-01
    Get full text
    Article
  6. 6
    DNA methylation-activated full-length EMX1 facilitates metastasis through EMX1-EGFR-ERK axis in hepatocellular carcinoma

    DNA methylation-activated full-length EMX1 facilitates metastasis through EMX1-EGFR-ERK axis in hepatocellular carcinoma by Dong-sheng Wen, Li-chang Huang, Xiao-yun Bu, Min-ke He, Zhi-cheng Lai, Ze-feng Du, Ye-xing Huang, Anna Kan, Ming Shi

    Published 2023-11-01
    Get full text
    Article
  7. 7
    Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma

    Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma by YeXing Huang, ZeFeng Du, Anna Kan, MinKe He, HuiFang Li, ZhiCheng Lai, DongSheng Wen, LiChang Huang, QiJiong Li, Li Xu, Ming Shi

    Published 2024-02-01
    Get full text
    Article
  8. 8
    Predictive factors for the benefit of triple‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma

    Predictive factors for the benefit of triple‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma by MinKe He, Qing Li, JingXian Shen, GuoSheng Tan, QiJiong Li, JiaYing Lai, Wei Wei, YaoJun Zhang, RuHai Zou, MinShan Chen, RongPing Guo, Ming Shi

    Published 2019-08-01
    Get full text
    Article
  9. 9
    Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials

    Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Su... by YeXing Huang MD, LiHong Zhang MD, MinKe He MD, ZhiCheng Lai MD, XiaoYun Bu MD, DongSheng Wen MD, QiJiong Li MD, Li Xu MD, Wei Wei MD, YaoJun Zhang MD, ZhongGuo Zhou MD, MinShan Chen MD, RongPing Guo MD, Ming Shi MD, Anna Kan MD

    Published 2022-12-01
    Get full text
    Article

Search Tools: